|
Dr. Stern received a Ph.D. in molecular biology and biotechnology from Tel Aviv University in 1994, and completed a postdoctoral fellowship at the U.S. National Institutes of Health (NIH). He has extensive academic and industry experience in cell and tissue engineering, and of a wide range of applied molecular and cellular biology technologies. From 2001 to 2004, Dr. Stern was group development leader of the microbiology section at Medgenics, where he spearheaded tissue engineering and development of the Biopump technology. From 2004 to 2006, he served as tissue engineering project manager at ProChon Biotech. Ltd, a company developing solutions to damaged cartilage. He rejoined Medgenics in his current role in 2006. | 